Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to take part in measurements at the Radboudumc hospital in Nijmegen, or if visiting in person is not possible, participation through home visits may be arranged instead.
- People who have a confirmed genetic diagnosis of LAMA2-related muscular dystrophy or SELENON-related myopathy, shown by two recessive disease-causing mutations in either the LAMA2 or SELENON gene.
- People who have typical clinical and physical features of one of these conditions, along with a confirmed genetic diagnosis in a close family member (such as a parent, sibling, or child).
- People who speak Dutch.
Who may not be able to join:
- People who do not have a sufficient understanding of the Dutch language.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +31611469112
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of Motor Function Measure (MFM)-32 (older than 7 years) of MFM-20 (2 to 7 years old)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.